Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity.
Mineishi, S
Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. [electronic resource] - Bone marrow transplantation Jun 1999 - 1217-22 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1701793 doi
Adolescent
Adult
Antimetabolites, Antineoplastic--administration & dosage
Bone Marrow Transplantation
Child
Child, Preschool
Combined Modality Therapy
Cytarabine--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Leukemia--drug therapy
Male
Middle Aged
Recurrence
Transplantation Conditioning
Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. [electronic resource] - Bone marrow transplantation Jun 1999 - 1217-22 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1701793 doi
Adolescent
Adult
Antimetabolites, Antineoplastic--administration & dosage
Bone Marrow Transplantation
Child
Child, Preschool
Combined Modality Therapy
Cytarabine--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Leukemia--drug therapy
Male
Middle Aged
Recurrence
Transplantation Conditioning